Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are increasingly recognized for their role in reducing the risk and improving the prognosis of heart failure (HF). However, the precise mechanisms involved re...

Source: Cardiovascular Diabetology - April 2, 2024 Category: Cardiology Authors: Wenqin Guo, Lingyue Zhao, Weichao Huang, Jing Chen, Tingting Zhong, Shaodi Yan, Wei Hu, Fanfang Zeng, Changnong Peng and Hongbing Yan Tags: Research Source Type: research